Results 31 to 40 of about 363,573 (256)

ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.

PLoS ONE, 2014
ENDOGLIN (ENG) is a co-receptor for transforming growth factor-β (TGF-β) family members that is highly expressed in endothelial cells and has a critical function in the development of the vascular system. Mutations in Eng are associated with the vascular
Zhen Liu, Franck Lebrin, Janita A Maring, Sander van den Driesche, Stieneke van der Brink, Maarten van Dinther, Midory Thorikay, Sabrina Martin, Kazuki Kobayashi, Lukas J A C Hawinkels, Laurens A van Meeteren, Evangelia Pardali, Jeroen Korving, Michelle Letarte, Helen M Arthur, Charles Theuer, Marie-José Goumans, Christine Mummery, Peter ten Dijke   +18 more
doaj   +1 more source

VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions [PDF]

, 2014
Vascular endothelial growth factor A (VEGF-A) regulates many aspects of vascular physiology. VEGF-A stimulates signal transduction pathways that modulate endothelial outputs such as cell migration, proliferation, tubulogenesis, and cell-cell interactions.
Abid MR, Abid MR, Adam F. Odell, Alexander F. Bruns, Antony M. Latham, Arthur JS, Baker M, Bartoli M, Bates DO, Bruns AF, Bruns AF, Butler JM, Carl-Henrik Heldin, Carmeliet P, Chen TT, Chung AS, Collins T, Cuhlmann S, Dejana E, Delcombel R, Ding BS, Ewan LC, Fearnley GW, Gareth W. Fearnley, Gerits N, Goddard LM, Griffioen AW, Harper SJ, Herve MA, Holmqvist K, Hordijk PL, Horowitz A, Howell GJ, Ian C. Zachary, Jain RK, Jopling HM, Jopling HM, Karihaloo A, Kawasaki H, Kawasaki H, Keyt BA, Kim I, Kim I, Koch S, Koch S, Lau E, Lemmon MA, Liu D, Meadows KL, Melder RJ, Monica C. Hollstein, Nadeem A. Mughal, Nakatsu MN, Nakayama M, Naldini A, Nicholas J. Burgoyne, Nourshargh S, Pan Q, Panne D, Plotnikov A, Reglero-Real N, Reimold AM, Rivera CG, Salameh A, Schweighofer B, Seko Y, Shalaby F, Shervanthi Homer-Vanniasinkam, Sixt M, Sreenivasan Ponnambalam, Stannard AK, Stephen B. Wheatcroft, Takahashi T, Testori J, Usui T, Weber C, Xu D, Zhang HT, Zhang Y   +78 more
core   +3 more sources

VEGF is indirectly associated with NO production

, 2012
Background? Increased levels of vascular endothelial growth factor (VEGF) have been observed in patients with metabolic syndrome (MetS). Nitric oxide (NO) formation is reduced in MetS, but its relationship to VEGF production remains poorly defined.
Alberti, Barylski, Bergman, Birk, Blann, Cao, Conover, Doupis, Dullaart, Ersoy, Hagberg, Jackson, Jackson, Kakizawa, Kimura, Kimura, Loebig, Sandhofer, Siervo, Siervo, Siervo, Siervo, Siervo, Silha, Simera, Treins, Tsai, Valabhji, Vyzantiadis   +28 more
core   +1 more source

Endothelial cells decode VEGF-mediated Ca2+ signaling patterns to produce distinct functional responses [PDF]

, 2016
A single extracellular stimulus can promote diverse behaviors among isogenic cells by differentially regulated signaling networks. We examined Ca2+ signaling in response to VEGF (vascular endothelial growth factor), a growth factor that can stimulate ...
Chou, Wesley H., Lee, Sung Hoon, Levchenko, Andre, Noren, David P., Popel, Aleksander S., Qutub, Amina A., Wagner, Daniel S., Warmflash, Aryeh   +7 more
core   +1 more source

Angiostatin Inhibition of Vascular Endothelial Growth Factor– Stimulated Nitric Oxide Production in Endothelial Cells

Journal of Pharmacological Sciences, 2010
Angiostatin (AS), a proteolytic fragment of plasminogen, is a potent antiangiogenic factor. It was reported that AS attenuates the vasodilatory response to vascular endothelial growth factor (VEGF) in isolated interventricular arterioles.
Satoru Takahashi, Tomohiro Shinya, Akinori Sugiyama   +2 more
doaj   +1 more source

Ropivacaine vs tetracaine in topical anesthesia for intravitreal injection [PDF]

, 2015
Aim: The object of the study was to evaluate the long term efficacy and safety of ropivacaine 0,5% vs tetracaine 0,5% for topical anesthesia in intravitreal injection of dexamethasone in patients with diabetic macular edema (DME) and anti-vascular ...
COLLINI, Saul, PACELLA, Elena, PACELLA, FERNANDA, SALDUCCI, Mauro, SMALDONE, GIANPAOLO, Troisi, Fabiana, TURCHETTI, PAOLO   +6 more
core   +1 more source

Porcine bone scaffolds adsorb growth factors secreted by MSCs and improve bone tissue repair [PDF]

, 2017
An ideal tissue-engineered bone graft should have both excellent pro-osteogenesis and pro-angiogenesis properties to rapidly realize the bone regeneration in vivo . To meet this goal, in this work a porcine bone scaffold was successfully used as a Trojan
Bressan, Eriberto, Ferroni, Letizia, Gardin, Chiara, Mijiritsky, Eitan, Piattelli, Adriano, Zanette, Gastone, Zavan, Barbara   +6 more
core   +5 more sources

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. [PDF]

, 2014
To enable new blood vessel growth, endothelial cells (ECs) express neuropilin 1 (NRP1), and NRP1 associates with the receptor tyrosine kinase VEGFR2 after binding the vascular endothelial growth factor A (VEGF) to enhance arteriogenesis.
Alessandro Fantin, Anastasia Lampropoulou, Anissa Chikh, Anselmi, Ballmer-Hofer, Baruzzi, Birukova, Buchdunger, Campochiaro, Carmeliet, Casanovas, Chen, Chen, Chislock, Cho, Choi, Christiana Ruhrberg, Clark, Claudio Raimondi, Colicelli, Connor, Cui, Cujec, Dejana, Druker, Fantin, Fantin, Fantin, Fantin, Foxton, Fukasawa, Gerhardt, Gerhardt, Herzog, Kawamura, Kawasaki, Kim, Kitsukawa, Koch, Lanahan, Lanahan, Laura Denti, Lewis, Lewis, Mamluk, Murga, Nishijima, Pan, Pan, Parsons, Pasapera, Phng, Raimondi, Ren, Robinson, Roig, Rosenfeld, Ruhrberg, Ruhrberg, Saint-Geniez, Salikhova, Shimizu, Shojaei, Smith, Soker, Sottile, Stenzel, Tvorogov, Uemura, Valdembri, Wang, Welti, Yaqoob, Zaidel-Bar, Zhuang   +74 more
core   +4 more sources

Antitumor Effect of Bevacizumab in a Xenograft Model of Canine Hemangiopericytoma

Journal of Pharmacological Sciences, 2013
.: Canine hemangiopericytoma (CHP) is characterized by frequent local recurrence and increased invasiveness. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis in tumors.
Masaki Michishita, Tatsuya Uto, Ryota Nakazawa, Hisashi Yoshimura, Kikumi Ogihara, Yuko Naya, Tsuyoshi Tajima, Daigo Azakami, Seigo Kishikawa, Toshiro Arai, Kimimasa Takahashi   +10 more
doaj   +1 more source

Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR‐major mutant NSCLC receiving osimertinib

Thoracic Cancer, 2023
Background Vascular endothelial growth factor (VEGF) has been identified as one of the resistant mechanisms to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs).
Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Kunihiko Kobayashi, Tomonori Kawasaki, Masanori Yasuda, Hiroshi Kagamu   +10 more
doaj   +1 more source